Clinical Trials Directory

Trials / Completed

CompletedNCT03893227

Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation

Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation: a Prevalence Study

Status
Completed
Phase
Study type
Observational
Enrollment
756 (actual)
Sponsor
Universitaire Ziekenhuizen KU Leuven · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Rhinitis, or inflammation of the nasal mucosa, can present with nasal obstruction, nasal discharge, itch or sneezing. If the sinusal mucosa is involved as well, it is called rhinosinusitis and facial pain or loss of smell is possible. Several causes are known, such as an underlying allergy ("allergic rhinitis", AR). If at least 2 symptoms are present for at least 12 weeks, it is called "chronic rhinosinusitis" (CRS). Up to 2/3 of the AR and CRS patients have symptoms upon exposure to triggers such as sudden temperature changes, smoke, fragrances… a phenomenon called "nasal hyperreactivity" (NHR). It is currently not clear why some patients suffer NHR while others do not. In this study, the investigators want to determine the prevalence and severity of nasal hyperreactivity in patients with chronic upper airway inflammation. To this end, patients and healthy controls will be asked to fill out a questionnaire inquiring presence and severity of nasal symptoms upon exposure to particular environmental triggers.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnairePatients and healthy controls will fill out a questionnaire

Timeline

Start date
2019-01-22
Primary completion
2020-09-30
Completion
2020-12-31
First posted
2019-03-28
Last updated
2021-03-12

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT03893227. Inclusion in this directory is not an endorsement.